An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis

Treatment of progressive multifocal leukoencephalopathy–immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab

(2015) Z. Calic et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Modifiable environmental factors in multiple sclerosis

(2014) Yara Dadalti Fragoso   ARQUIVOS DE NEURO-PSIQUIATRIA

The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review

(2014) Dimitrios Karussis   JOURNAL OF AUTOIMMUNITY

Sodium intake is associated with increased disease activity in multiple sclerosis

(2014) Mauricio F Farez et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

(2014) Christian Confavreux et al.   LANCET NEUROLOGY

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety

(2013) Robert J. Fox et al.   CURRENT MEDICAL RESEARCH AND OPINION

Environmental factors in multiple sclerosis

(2013) Alberto Ascherio   Expert Review of Neurotherapeutics

Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1

(2013) Chuan Wu et al.   NATURE

Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells

(2013) Markus Kleinewietfeld et al.   NATURE

Disability in multiple sclerosis: A reference for patients and clinicians

(2013) I. Kister et al.   NEUROLOGY

PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy

(2013) Bob W. van Oosten et al.   NEW ENGLAND JOURNAL OF MEDICINE

PML in a Patient Treated with Fumaric Acid

(2013) Ummehan Ermis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sudden unexpected death on fingolimod

(2012) JW Lindsey et al.   Multiple Sclerosis Journal

Treatment of Acute Relapses in Multiple Sclerosis

(2012) Regina Berkovich   Neurotherapeutics

Fingolimod for Multiple Sclerosis

(2012) Daniel Pelletier et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Pathology of Demyelinating Diseases

(2011) Bogdan F.Gh. Popescu et al.   Annual Review of Pathology-Mechanisms of Disease

Immune-mediated CNS diseases: A review on nosological classification and clinical features

(2011) Uwe K. Zettl et al.   AUTOIMMUNITY REVIEWS

Environmental factors in early childhood are associated with multiple sclerosis: a case-control study

(2011) Silja Conradi et al.   BMC Neurology

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

(2011) Ralf A. Linker et al.   BRAIN

Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis

(2011) Owain W. Howell et al.   BRAIN

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

(2011) S. Simpson et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

(2011) Stephen Sawcer et al.   NATURE

Inflammatory Cortical Demyelination in Early Multiple Sclerosis

(2011) Claudia F. Lucchinetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

(2011) Paul O'Connor et al.   NEW ENGLAND JOURNAL OF MEDICINE

Smoking: effects on multiple sclerosis susceptibility and disease progression

(2011) Dean M. Wingerchuk   Therapeutic Advances in Neurological Disorders

Pathophysiology of multiple sclerosis and the place of teriflunomide

(2010) R. Gold et al.   ACTA NEUROLOGICA SCANDINAVICA

Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm

(2010) Helena Batoulis et al.   ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER

Vitamin D and multiple sclerosis

(2010) Alberto Ascherio et al.   LANCET NEUROLOGY

Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial

(2010) R. T. Naismith et al.   NEUROLOGY

MRI criteria for MS in patients with clinically isolated syndromes

(2010) X. Montalban et al.   NEUROLOGY

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

(2010) Jeffrey A. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunomodulatory effects of Vitamin D in multiple sclerosis

(2009) J. Correale et al.   BRAIN

The relation between inflammation and neurodegeneration in multiple sclerosis brains

(2009) Josa M. Frischer et al.   BRAIN

Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis

(2009) Amer Awad et al.   JOURNAL OF NEUROIMMUNOLOGY

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

(2008) C. F. Lucchinetti et al.   BRAIN

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Grey matter pathology in multiple sclerosis

(2008) Jeroen JG Geurts et al.   LANCET NEUROLOGY

Genetics and Natural History of Multiple Sclerosis

(2008) Orhun Kantarci   SEMINARS IN NEUROLOGY

Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis

(2007) John S. Tzartos et al.   AMERICAN JOURNAL OF PATHOLOGY